PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
33083764-3	2020	Detailed lipid profiling revealed that inhibition of FASN resulted in significant reduction of sphingolipids and phosphatidylcholine (PC); moreover, we found that PC was the key metabolite for cell survival in hPSCs.	Phosphatidylcholines	113-132	fatty acid synthase	Homo sapiens	53-57	
33083764-3	2020	Detailed lipid profiling revealed that inhibition of FASN resulted in significant reduction of sphingolipids and phosphatidylcholine (PC); moreover, we found that PC was the key metabolite for cell survival in hPSCs.	Phosphatidylcholines	134-136	fatty acid synthase	Homo sapiens	53-57	
33083764-3	2020	Detailed lipid profiling revealed that inhibition of FASN resulted in significant reduction of sphingolipids and phosphatidylcholine (PC); moreover, we found that PC was the key metabolite for cell survival in hPSCs.	Phosphatidylcholines	163-165	fatty acid synthase	Homo sapiens	53-57	
23816424-9	2013	FASN inhibitor treated Y79 RB and fibroblast cells showed decrease in the cellular lipids (triglyceride, cholesterol and phosphatidyl choline) levels.	Phosphatidylcholines	121-141	fatty acid synthase	Homo sapiens	0-4	
18723500-6	2008	Furthermore, we have determined that FASN inhibition results not only in lower phosphatidylcholine levels but also in a 59% drop in the phospholipid precursor phosphocholine (PCho).	Phosphatidylcholines	79-98	fatty acid synthase	Homo sapiens	37-41